Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: An enzyme activity study

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 131, Issue 3, 2002, Pages 475-482

  Moesgaard, Birthe ^a   Petersen, Gitte ^a   Mortensen, Svend A ^b   Hansen, Harald S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Anandamide; Development; Endocannabinoid; Heart; N Acyl ethanolamine phospholipid hydrolyzing phospholipase D; N Acyl ethanolamine phospholipids; N Acyl transferase; Species differences

Indexed keywords

ACYLTRANSFERASE; ANANDAMIDE; ETHANOLAMINE DERIVATIVE; PHOSPHOLIPASE D; PHOSPHOLIPID;

ADULT; ANIMAL TISSUE; ARTICLE; BRAIN; CAT; CATALYSIS; CONTROLLED STUDY; COW; DOG; ENZYME ACTIVITY; FEMALE; FROG; GUINEA PIG; HEART; HUMAN; HUMAN TISSUE; LIPID DEGRADATION; MALE; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SPECIES DIFFERENCE; SWINE;

ANURA; CANIS FAMILIARIS; CAVIA; FELIS CATUS; ORYCTOLAGUS CUNICULUS;

EID: 0036186465     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-4959(02)00003-9     Document Type: Article

References (26)

1. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues
2. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding
3. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
4. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
5. N-Acylethanolamine accumulation in infarcted myocardium
6. Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium
7. 2+ release from mitochondria by N-acylethanolamines, a class of lipids synthesized in ischemic heart tissue
8. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
9. A reappraisal of the dog-heart infarct plasmalogen. Its conception as a bis-phosphatidic acid and current recognition as an N-acyl phosphatidyl ethanolamine
10. N-Acylethanolamines and precursor phospholipids - Relation to cell injury
11. Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death
12. Endocannabinoids and vascular function
13. Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues
14. Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide
15. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
16. 31P NMR study
17. 31P NMR and enzyme activity study
18. N-Acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate
19. A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: Application to N-acylethanolamine formation in vitro
20. The endocannabinoid system as a target for therapeutic drugs
21. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation
22. N-Acylated glycerophospholipids and their derivatives
23. Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type
24. A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols
25. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor - Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
26. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain